Spots Global Cancer Trial Database for urinary bladder neoplasm
Every month we try and update this database with for urinary bladder neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses | NCT05097105 | Urinary Bladder... | MRI | 18 Years - | Sohag University | |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | NCT04561362 | Advanced Solid ... Urinary Bladder... Triple Negative... Carcinoma, Non-... Ovarian Neoplas... | BT8009 Pembrolizumab | 18 Years - | BicycleTx Limited | |
| Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours | NCT04029948 | Urinary Bladder... | Laser En Bloc R... Electro-surgica... | - | Mansoura University | |
| Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy | NCT04442724 | Bladder Cancer Urinary Bladder... Urologic Neopla... Neoplasms Urinary Bladder... | Fiducial marker... Multiparametric... | 18 Years - | Cedars-Sinai Medical Center | |
| The Importance of Muscle Function in Patients With Disseminated Bladder Cancer | NCT04144270 | Urinary Bladder... | Evaluation of m... | 18 Years - | Rigshospitalet, Denmark | |
| The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial | NCT02966535 | Prostatic Neopl... Urinary Bladder... | Adjustment of M... Adjustment of M... | 20 Years - 90 Years | Seoul National University Hospital | |
| Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | NCT06237920 | Urologic Neopla... Urogenital Neop... Neoplasms by Si... Neoplasms Female Urogenit... Female Urogenit... Urogenital Dise... Urinary Bladder... Male Urogenital... Urinary Bladder... Antineoplastics... | Nivolumab Relatlimab | 18 Years - | The Netherlands Cancer Institute | |
| A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors | NCT02952989 | Carcinoma, Non-... Carcinoma, Rena... Breast Neoplasm... Urinary Bladder... Carcinoma, Squa... Colorectal Neop... Gastric Adenoca... Gastroesophagea... | SGN-2FF pembrolizumab | 18 Years - | Seagen Inc. | |
| Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma | NCT03389438 | Urinary Bladder... | autologous Tcm ... | 18 Years - 75 Years | Beijing Huanxing Cancer Hospital | |
| A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors | NCT03914794 | Bladder Cancer NMIBC Non-Muscle Inva... Urothelial Carc... | Pemigatinib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors | NCT02952989 | Carcinoma, Non-... Carcinoma, Rena... Breast Neoplasm... Urinary Bladder... Carcinoma, Squa... Colorectal Neop... Gastric Adenoca... Gastroesophagea... | SGN-2FF pembrolizumab | 18 Years - | Seagen Inc. | |
| Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | NCT06237920 | Urologic Neopla... Urogenital Neop... Neoplasms by Si... Neoplasms Female Urogenit... Female Urogenit... Urogenital Dise... Urinary Bladder... Male Urogenital... Urinary Bladder... Antineoplastics... | Nivolumab Relatlimab | 18 Years - | The Netherlands Cancer Institute | |
| Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery | NCT02977143 | Prostatic Neopl... Urinary Bladder... | Fluid loading o... | 20 Years - | Seoul National University Hospital | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Evaluation of NanoDoce® in Participants With Urothelial Carcinoma | NCT03636256 | Bladder Cancer Urothelial Carc... Urinary Bladder... Urinary Bladder... Urogenital Neop... Urologic Neopla... Urologic Cancer Malignant Tumor... Cancer of the B... | NanoDoce (direc... NanoDoce (intra... Institutional S... NanoDoce (intra... | 18 Years - | NanOlogy, LLC | |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | NCT04561362 | Advanced Solid ... Urinary Bladder... Triple Negative... Carcinoma, Non-... Ovarian Neoplas... | BT8009 Pembrolizumab | 18 Years - | BicycleTx Limited | |
| The Importance of Muscle Function in Patients With Disseminated Bladder Cancer | NCT04144270 | Urinary Bladder... | Evaluation of m... | 18 Years - | Rigshospitalet, Denmark | |
| Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors | NCT01446822 | Neoplasm of Lat... | Bipolar transur... Monopolar trans... | 18 Years - | Cantonal Hospital of St. Gallen | |
| Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder | NCT04576286 | Urinary Bladder... | Holmium versus ... | 18 Years - | Ain Shams University | |
| SOX2 & PDL1 Expression on Urinary Bladder Carcinoma | NCT05429710 | Urinary Bladder... | - | Sohag University | ||
| CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood | NCT04811846 | Urinary Bladder... Transitional Ce... Urogenital Neop... Circulating Tum... Neoplasms | Bipolar transur... Bipolar transur... | 18 Years - | University Teaching Hospital Hall in Tirol | |
| Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery | NCT02977143 | Prostatic Neopl... Urinary Bladder... | Fluid loading o... | 20 Years - | Seoul National University Hospital | |
| Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer | NCT05946369 | Urinary Bladder... Urinary Bladder... BCG Trans Urethral ... Non-Muscle Inva... | Neutrophil to l... | - | Ain Shams University | |
| Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors | NCT01446822 | Neoplasm of Lat... | Bipolar transur... Monopolar trans... | 18 Years - | Cantonal Hospital of St. Gallen | |
| Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma | NCT03389438 | Urinary Bladder... | autologous Tcm ... | 18 Years - 75 Years | Beijing Huanxing Cancer Hospital | |
| Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | NCT01261299 | Carcinoma, Non-... Urinary Bladder... | Carbon-14-label... | 18 Years - | University of California, Davis | |
| A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer | NCT03785925 | Urinary Bladder... Neoplasm Metast... | Bempegaldesleuk... Nivolumab | 18 Years - | Nektar Therapeutics | |
| Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma | NCT03389438 | Urinary Bladder... | autologous Tcm ... | 18 Years - 75 Years | Beijing Huanxing Cancer Hospital | |
| Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder | NCT04576286 | Urinary Bladder... | Holmium versus ... | 18 Years - | Ain Shams University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
